Kinshasa — When Ebola hit the city of Mbandaka in northwest Congo in 2018, health officials had to act fast — the city was connected via regular boat service to the sprawling capital Kinshasa, where the deadly virus could spread out of control.
Unlike in previous outbreaks, they had a new weapon — an experimental vaccine that could revolutionise the fight against Ebola — if they could keep the vials between -60 to -80°C in tropical humidity and across rough terrain...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.